Clinical Trial Update: A Study of Apatinib in Recurrent or Recurrent High-grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating apatinib in patients with recurrent high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• High-grade Glioma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: West China Hospital | Conditions: Glioma | Phase 2 | Status: UNKNOWN